Group One Trading
TCRT icon

Group One Trading’s Alaunos Therapeutics TCRT Stock Holding History

Group One Trading’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,300
Closed -$13.9K – 8364
2024
Q4 		$13.9K Hold
7,300
– – ﹤0.01% 5922
2024
Q3 		$24K Buy
7,300
+6,570
+900% +$23.6K ﹤0.01% 5137
2024
Q2 		$5.1K Sell
730
-100
-12% -$1.19K ﹤0.01% 5945
2024
Q1 		$15K Buy
830
+221
+36% +$4.42K ﹤0.01% 5624
2023
Q4 		$6.46K Hold
609
– – ﹤0.01% 6412
2023
Q3 		$12K Sell
609
-158
-21% -$6.81K ﹤0.01% 6240
2023
Q2 		$58.6K Sell
767
-686
-47% -$55.5K ﹤0.01% 5139
2023
Q1 		$137K Sell
1,453
-1,092
-43% -$104K ﹤0.01% 4011
2022
Q4 		$248K Sell
2,545
-478
-16% -$69.3K ﹤0.01% 3680
2022
Q3 		$780K Buy
3,023
+1,832
+154% +$532K ﹤0.01% 2815
2022
Q2 		$222K Sell
1,191
-1,356
-53% -$130K ﹤0.01% 4194
2022
Q1 		$249K Sell
2,547
-3,627
-59% -$466K ﹤0.01% 4569
2021
Q4 		$1.01M Buy
6,174
+418
+7% +$91.9K ﹤0.01% 3357
2021
Q3 		$1.57M Buy
5,756
+2,973
+107% +$909K ﹤0.01% 2907
2021
Q2 		$1.1M Sell
2,783
-1,356
-33% -$633K ﹤0.01% 3299
2021
Q1 		$2.23M Buy
4,139
+1,802
+77% +$1.12M ﹤0.01% 2351
2020
Q4 		$883K Sell
2,337
-1,369
-37% -$544K ﹤0.01% 2759
2020
Q3 		$1.4M Buy
3,706
+231
+7% +$102K ﹤0.01% 1892
2020
Q2 		$1.71M Buy
3,475
+233
+7% +$104K 0.01% 1584
2020
Q1 		$1.19M Sell
3,242
-469
-13% -$243K 0.01% 1392
2019
Q4 		$2.63M Buy
3,711
+628
+20% +$432K 0.02% 1083
2019
Q3 		$1.98M Buy
3,083
+859
+39% +$681K 0.02% 1229
2019
Q2 		$1.95M Sell
2,224
-388
-15% -$267K 0.02% 1105
2019
Q1 		$1.51M Buy
2,612
+34
+1% +$14.2K 0.02% 1123
2018
Q4 		$723K Buy
2,578
+2,351
+1,036% +$929K 0.01% 1737
2018
Q3 		$109K Sell
227
-90
-28% -$38.6K ﹤0.01% 3473
2018
Q2 		$143K Sell
317
-1,268
-80% -$804K ﹤0.01% 3322
2018
Q1 		$932K Buy
1,585
+1,172
+284% +$730K 0.01% 1582
2017
Q4 		$257K Sell
413
-776
-65% -$558K ﹤0.01% 2770
2017
Q3 		$1.09M Sell
1,189
-862
-42% -$766K 0.01% 1491
2017
Q2 		$1.91M Sell
2,051
-44
-2% -$43.1K 0.02% 980
2017
Q1 		$1.99M Sell
2,095
-340
-14% -$317K 0.02% 869
2016
Q4 		$1.95M Sell
2,435
-1,240
-34% -$1.12M 0.02% 936
2016
Q3 		$3.1M Buy
3,675
+236
+7% +$190K 0.03% 620
2016
Q2 		$2.83M Buy
3,439
+44
+1% +$47.9K 0.03% 624
2016
Q1 		$3.78M Sell
3,395
-52
-2% -$53.2K 0.05% 456
2015
Q4 		$4.3M Sell
3,447
-1,516
-31% -$2.51M 0.05% 440
2015
Q3 		$6.71M Buy
4,963
+611
+14% +$1.01M 0.09% 252
2015
Q2 		$7.83M Sell
4,352
-2,691
-38% -$4.18M 0.11% 194
2015
Q1 		$11.4M Buy
7,043
+4,728
+204% +$7.01M 0.18% 89
2014
Q4 		$1.76M Buy
2,315
+502
+28% +$266K 0.03% 712
2014
Q3 		$718K Buy
1,813
+289
+19% +$139K 0.01% 1337
2014
Q2 		$921K Sell
1,524
-2,367
-61% -$1.32M 0.01% 1194
2014
Q1 		$2.67M Sell
3,891
-1,263
-25% -$846K 0.05% 494
2013
Q4 		$3.35M Buy
5,154
+2,095
+68% +$1.25M 0.05% 390
2013
Q3 		$1.81M Buy
3,059
+590
+24% +$266K 0.03% 621
2013
Q2 		$778K Buy
+2,469
New +$686K 0.02% 992

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Group One Trading's TCRT Position: Q3 2025 in Review

Group One Trading sold out of Alaunos Therapeutics (TCRT) in Q3 2025, closing a stake of 300 shares — an estimated $1.46K sold.

Group One Trading first reported a position in TCRT in Q2 2013 and held it in 48 quarters. The position peaked at $4.96M in Q2 2015. 26 funds tracked by Wall St. Rank hold TCRT as of Q3 2025.

  • Group One Trading reported no remaining Alaunos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 300 Alaunos Therapeutics shares in Q3 2025, an estimated $1.46K.
  • Group One Trading first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 48 quarters.
  • Group One Trading's Alaunos Therapeutics position peaked at $4.96M in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.